3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalence of all epilepsies in urban informal settlements in Nairobi, Kenya: a two-stage population-based study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Background

          WHO estimates that more than 50 million people worldwide have epilepsy and 80% of cases are in low-income and middle-income countries. Most studies in Africa have focused on active convulsive epilepsy in rural areas, but there are few data in urban settings. We aimed to estimate the prevalence and spatial distribution of all epilepsies in two urban informal settlements in Nairobi, Kenya.

          Methods

          We did a two-stage population-based cross-sectional study of residents in a demographic surveillance system covering two informal settlements in Nairobi, Kenya (Korogocho and Viwandani). Stage 1 screened all household members using a validated epilepsy screening questionnaire to detect possible cases. In stage 2, those identified with possible seizures and a proportion of those screening negative were invited to local clinics for clinical and neurological assessments by a neurologist. Seizures were classified following the International League Against Epilepsy recommendations. We adjusted for attrition between the two stages using multiple imputations and for sensitivity by dividing estimates by the sensitivity value of the screening tool. Complementary log–log regression was used to assess prevalence differences by participant socio-demographics.

          Findings

          A total of 56 425 individuals were screened during stage 1 (between Sept 17 and Dec 23, 2021) during which 1126 were classified as potential epilepsy cases. A total of 873 were assessed by a neurologist in stage 2 (between April 12 and Aug 6, 2022) during which 528 were confirmed as epilepsy cases. 253 potential cases were not assessed by a neurologist due to attrition. 30 179 (53·5%) of the 56 425 individuals were male and 26 246 (46·5%) were female. The median age was 24 years (IQR 11–35). Attrition-adjusted and sensitivity-adjusted prevalence for all types of epilepsy was 11·9 cases per 1000 people (95% CI 11·0–12·8), convulsive epilepsy was 8·7 cases per 1000 people (8·0–9·6), and non-convulsive epilepsy was 3·2 cases per 1000 people (2·7–3·7). Overall prevalence was highest among separated or divorced individuals at 20·3 cases per 1000 people (95% CI 15·9–24·7), unemployed people at 18·8 cases per 1000 people (16·2–21·4), those with no formal education at 18·5 cases per 1000 people (16·3–20·7), and adolescents aged 13–18 years at 15·2 cases per 1000 people (12·0–18·5). The epilepsy diagnostic gap was 80%.

          Interpretation

          Epilepsy is common in urban informal settlements of Nairobi, with large diagnostic gaps. Targeted interventions are needed to increase early epilepsy detection, particularly among vulnerable groups, to enable prompt treatment and prevention of adverse social consequences.

          Funding

          National Institute for Health Research using Official Development Assistance.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

          The International League Against Epilepsy (ILAE) Classification of the Epilepsies has been updated to reflect our gain in understanding of the epilepsies and their underlying mechanisms following the major scientific advances that have taken place since the last ratified classification in 1989. As a critical tool for the practicing clinician, epilepsy classification must be relevant and dynamic to changes in thinking, yet robust and translatable to all areas of the globe. Its primary purpose is for diagnosis of patients, but it is also critical for epilepsy research, development of antiepileptic therapies, and communication around the world. The new classification originates from a draft document submitted for public comments in 2013, which was revised to incorporate extensive feedback from the international epilepsy community over several rounds of consultation. It presents three levels, starting with seizure type, where it assumes that the patient is having epileptic seizures as defined by the new 2017 ILAE Seizure Classification. After diagnosis of the seizure type, the next step is diagnosis of epilepsy type, including focal epilepsy, generalized epilepsy, combined generalized, and focal epilepsy, and also an unknown epilepsy group. The third level is that of epilepsy syndrome, where a specific syndromic diagnosis can be made. The new classification incorporates etiology along each stage, emphasizing the need to consider etiology at each step of diagnosis, as it often carries significant treatment implications. Etiology is broken into six subgroups, selected because of their potential therapeutic consequences. New terminology is introduced such as developmental and epileptic encephalopathy. The term benign is replaced by the terms self-limited and pharmacoresponsive, to be used where appropriate. It is hoped that this new framework will assist in improving epilepsy care and research in the 21st century.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology

            The International League Against Epilepsy (ILAE) presents a revised operational classification of seizure types. The purpose of such a revision is to recognize that some seizure types can have either a focal or generalized onset, to allow classification when the onset is unobserved, to include some missing seizure types, and to adopt more transparent names. Because current knowledge is insufficient to form a scientifically based classification, the 2017 Classification is operational (practical) and based on the 1981 Classification, extended in 2010. Changes include the following: (1) "partial" becomes "focal"; (2) awareness is used as a classifier of focal seizures; (3) the terms dyscognitive, simple partial, complex partial, psychic, and secondarily generalized are eliminated; (4) new focal seizure types include automatisms, behavior arrest, hyperkinetic, autonomic, cognitive, and emotional; (5) atonic, clonic, epileptic spasms, myoclonic, and tonic seizures can be of either focal or generalized onset; (6) focal to bilateral tonic-clonic seizure replaces secondarily generalized seizure; (7) new generalized seizure types are absence with eyelid myoclonia, myoclonic absence, myoclonic-atonic, myoclonic-tonic-clonic; and (8) seizures of unknown onset may have features that can still be classified. The new classification does not represent a fundamental change, but allows greater flexibility and transparency in naming seizure types.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

              To review population-based studies of the prevalence and incidence of epilepsy worldwide and use meta-analytic techniques to explore factors that may explain heterogeneity between estimates.
                Bookmark

                Author and article information

                Contributors
                Journal
                Lancet Glob Health
                Lancet Glob Health
                The Lancet. Global Health
                Elsevier Ltd
                2214-109X
                05 July 2024
                August 2024
                05 July 2024
                : 12
                : 8
                : e1323-e1330
                Affiliations
                [a ]African Population and Health Research Center, Nairobi, Kenya
                [b ]Department of Mathematics, University of Nairobi, Nairobi, Kenya
                [c ]Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya
                [d ]Department of Statistics and Economics, Kabale University, Kabale, Uganda
                [e ]Department of Public & Occupational Health, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, Netherlands
                [f ]Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
                [g ]Department of Statistics and Actuarial Science, University of Ghana, Accra, Ghana
                [h ]Oxford Epilepsy Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
                [i ]Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK
                [j ]Department of Psychiatry, University of Oxford, Oxford, UK
                [k ]Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK
                [l ]Department of Clinical & Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK
                [m ]Chalfont Centre for Epilepsy, Buckinghamshire, UK
                [n ]Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands
                [o ]Neurology Department, West China Hospital, Sichuan University, Chengdu, China
                [p ]Kenya Medical Research Institute–Wellcome Trust Research Programme, Kilifi, Kenya
                [q ]Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden
                [r ]Department of Public Health, Pwani University, Kilifi, Kenya
                [s ]The Centre for Global Epilepsy, University of Oxford, Oxford, UK
                Author notes
                [* ]Correspondence to: Daniel Mtai Mwanga, African Population and Health Research Center, PO Box 10787-00100 Nairobi, Kenya dmwanga@ 123456aphrc.org
                [†]

                Members listed at the end of the Article

                Article
                S2214-109X(24)00217-1
                10.1016/S2214-109X(24)00217-1
                11254782
                38976998
                962f5856-6781-4564-a943-987f225b5d23
                © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC ND 4.0 license

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Articles

                Comments

                Comment on this article